The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preclinical Oncology CRO Market Research Report 2025
Synopsis
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The global Preclinical Oncology CRO market was valued at US$ 380.3 million in 2023 and is anticipated to reach US$ 876.2 million by 2030, witnessing a CAGR of 12.4% during the forecast period 2024-2030.
The industry's leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.
This report aims to provide a comprehensive presentation of the global market for Preclinical Oncology CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Oncology CRO.
Report Scope
The Preclinical Oncology CRO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical Oncology CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Oncology CRO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Crown Bioscience
Charles River Laboratory
ICON Plc.
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
Wuxi AppTec.
MI Bioresearch, Inc.
Champion Oncology, Inc.
Xentech
Segment by Type
Blood Cancer
Solid Tumors
Other
Segment by Application
In Vitro
In Vivo
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Oncology CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The global Preclinical Oncology CRO market was valued at US$ 380.3 million in 2023 and is anticipated to reach US$ 876.2 million by 2030, witnessing a CAGR of 12.4% during the forecast period 2024-2030.
The industry's leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.
This report aims to provide a comprehensive presentation of the global market for Preclinical Oncology CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Oncology CRO.
Report Scope
The Preclinical Oncology CRO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical Oncology CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Oncology CRO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Crown Bioscience
Charles River Laboratory
ICON Plc.
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
Wuxi AppTec.
MI Bioresearch, Inc.
Champion Oncology, Inc.
Xentech
Segment by Type
Blood Cancer
Solid Tumors
Other
Segment by Application
In Vitro
In Vivo
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Oncology CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Oncology CRO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Cancer
1.2.3 Solid Tumors
1.2.4 Other
1.3 Market by Application
1.3.1 Global Preclinical Oncology CRO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 In Vitro
1.3.3 In Vivo
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical Oncology CRO Market Perspective (2019-2030)
2.2 Preclinical Oncology CRO Growth Trends by Region
2.2.1 Global Preclinical Oncology CRO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preclinical Oncology CRO Historic Market Size by Region (2019-2024)
2.2.3 Preclinical Oncology CRO Forecasted Market Size by Region (2025-2030)
2.3 Preclinical Oncology CRO Market Dynamics
2.3.1 Preclinical Oncology CRO Industry Trends
2.3.2 Preclinical Oncology CRO Market Drivers
2.3.3 Preclinical Oncology CRO Market Challenges
2.3.4 Preclinical Oncology CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical Oncology CRO Players by Revenue
3.1.1 Global Top Preclinical Oncology CRO Players by Revenue (2019-2024)
3.1.2 Global Preclinical Oncology CRO Revenue Market Share by Players (2019-2024)
3.2 Global Preclinical Oncology CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preclinical Oncology CRO Revenue
3.4 Global Preclinical Oncology CRO Market Concentration Ratio
3.4.1 Global Preclinical Oncology CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Oncology CRO Revenue in 2023
3.5 Preclinical Oncology CRO Key Players Head office and Area Served
3.6 Key Players Preclinical Oncology CRO Product Solution and Service
3.7 Date of Enter into Preclinical Oncology CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical Oncology CRO Breakdown Data by Type
4.1 Global Preclinical Oncology CRO Historic Market Size by Type (2019-2024)
4.2 Global Preclinical Oncology CRO Forecasted Market Size by Type (2025-2030)
5 Preclinical Oncology CRO Breakdown Data by Application
5.1 Global Preclinical Oncology CRO Historic Market Size by Application (2019-2024)
5.2 Global Preclinical Oncology CRO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preclinical Oncology CRO Market Size (2019-2030)
6.2 North America Preclinical Oncology CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preclinical Oncology CRO Market Size by Country (2019-2024)
6.4 North America Preclinical Oncology CRO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical Oncology CRO Market Size (2019-2030)
7.2 Europe Preclinical Oncology CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preclinical Oncology CRO Market Size by Country (2019-2024)
7.4 Europe Preclinical Oncology CRO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Oncology CRO Market Size (2019-2030)
8.2 Asia-Pacific Preclinical Oncology CRO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preclinical Oncology CRO Market Size by Region (2019-2024)
8.4 Asia-Pacific Preclinical Oncology CRO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical Oncology CRO Market Size (2019-2030)
9.2 Latin America Preclinical Oncology CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preclinical Oncology CRO Market Size by Country (2019-2024)
9.4 Latin America Preclinical Oncology CRO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Oncology CRO Market Size (2019-2030)
10.2 Middle East & Africa Preclinical Oncology CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preclinical Oncology CRO Market Size by Country (2019-2024)
10.4 Middle East & Africa Preclinical Oncology CRO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Detail
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Preclinical Oncology CRO Introduction
11.1.4 Crown Bioscience Revenue in Preclinical Oncology CRO Business (2019-2024)
11.1.5 Crown Bioscience Recent Development
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Detail
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Preclinical Oncology CRO Introduction
11.2.4 Charles River Laboratory Revenue in Preclinical Oncology CRO Business (2019-2024)
11.2.5 Charles River Laboratory Recent Development
11.3 ICON Plc.
11.3.1 ICON Plc. Company Detail
11.3.2 ICON Plc. Business Overview
11.3.3 ICON Plc. Preclinical Oncology CRO Introduction
11.3.4 ICON Plc. Revenue in Preclinical Oncology CRO Business (2019-2024)
11.3.5 ICON Plc. Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Detail
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Preclinical Oncology CRO Introduction
11.4.4 Eurofins Scientific Revenue in Preclinical Oncology CRO Business (2019-2024)
11.4.5 Eurofins Scientific Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Detail
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Preclinical Oncology CRO Introduction
11.5.4 Taconic Biosciences Revenue in Preclinical Oncology CRO Business (2019-2024)
11.5.5 Taconic Biosciences Recent Development
11.6 Covance
11.6.1 Covance Company Detail
11.6.2 Covance Business Overview
11.6.3 Covance Preclinical Oncology CRO Introduction
11.6.4 Covance Revenue in Preclinical Oncology CRO Business (2019-2024)
11.6.5 Covance Recent Development
11.7 EVOTEC
11.7.1 EVOTEC Company Detail
11.7.2 EVOTEC Business Overview
11.7.3 EVOTEC Preclinical Oncology CRO Introduction
11.7.4 EVOTEC Revenue in Preclinical Oncology CRO Business (2019-2024)
11.7.5 EVOTEC Recent Development
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Detail
11.8.2 The Jackson Laboratory Business Overview
11.8.3 The Jackson Laboratory Preclinical Oncology CRO Introduction
11.8.4 The Jackson Laboratory Revenue in Preclinical Oncology CRO Business (2019-2024)
11.8.5 The Jackson Laboratory Recent Development
11.9 Wuxi AppTec.
11.9.1 Wuxi AppTec. Company Detail
11.9.2 Wuxi AppTec. Business Overview
11.9.3 Wuxi AppTec. Preclinical Oncology CRO Introduction
11.9.4 Wuxi AppTec. Revenue in Preclinical Oncology CRO Business (2019-2024)
11.9.5 Wuxi AppTec. Recent Development
11.10 MI Bioresearch, Inc.
11.10.1 MI Bioresearch, Inc. Company Detail
11.10.2 MI Bioresearch, Inc. Business Overview
11.10.3 MI Bioresearch, Inc. Preclinical Oncology CRO Introduction
11.10.4 MI Bioresearch, Inc. Revenue in Preclinical Oncology CRO Business (2019-2024)
11.10.5 MI Bioresearch, Inc. Recent Development
11.11 Champion Oncology, Inc.
11.11.1 Champion Oncology, Inc. Company Detail
11.11.2 Champion Oncology, Inc. Business Overview
11.11.3 Champion Oncology, Inc. Preclinical Oncology CRO Introduction
11.11.4 Champion Oncology, Inc. Revenue in Preclinical Oncology CRO Business (2019-2024)
11.11.5 Champion Oncology, Inc. Recent Development
11.12 Xentech
11.12.1 Xentech Company Detail
11.12.2 Xentech Business Overview
11.12.3 Xentech Preclinical Oncology CRO Introduction
11.12.4 Xentech Revenue in Preclinical Oncology CRO Business (2019-2024)
11.12.5 Xentech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Preclinical Oncology CRO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Blood Cancer
Table 3. Key Players of Solid Tumors
Table 4. Key Players of Other
Table 5. Global Preclinical Oncology CRO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Preclinical Oncology CRO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Preclinical Oncology CRO Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Preclinical Oncology CRO Market Share by Region (2019-2024)
Table 9. Global Preclinical Oncology CRO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Preclinical Oncology CRO Market Share by Region (2025-2030)
Table 11. Preclinical Oncology CRO Market Trends
Table 12. Preclinical Oncology CRO Market Drivers
Table 13. Preclinical Oncology CRO Market Challenges
Table 14. Preclinical Oncology CRO Market Restraints
Table 15. Global Preclinical Oncology CRO Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Preclinical Oncology CRO Market Share by Players (2019-2024)
Table 17. Global Top Preclinical Oncology CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Oncology CRO as of 2023)
Table 18. Ranking of Global Top Preclinical Oncology CRO Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Preclinical Oncology CRO Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Preclinical Oncology CRO Product Solution and Service
Table 22. Date of Enter into Preclinical Oncology CRO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Preclinical Oncology CRO Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Preclinical Oncology CRO Revenue Market Share by Type (2019-2024)
Table 26. Global Preclinical Oncology CRO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Preclinical Oncology CRO Revenue Market Share by Type (2025-2030)
Table 28. Global Preclinical Oncology CRO Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Preclinical Oncology CRO Revenue Market Share by Application (2019-2024)
Table 30. Global Preclinical Oncology CRO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Preclinical Oncology CRO Revenue Market Share by Application (2025-2030)
Table 32. North America Preclinical Oncology CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Preclinical Oncology CRO Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Preclinical Oncology CRO Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Preclinical Oncology CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Preclinical Oncology CRO Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Preclinical Oncology CRO Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Preclinical Oncology CRO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Preclinical Oncology CRO Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Preclinical Oncology CRO Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Preclinical Oncology CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Preclinical Oncology CRO Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Preclinical Oncology CRO Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Preclinical Oncology CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Preclinical Oncology CRO Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Preclinical Oncology CRO Market Size by Country (2025-2030) & (US$ Million)
Table 47. Crown Bioscience Company Detail
Table 48. Crown Bioscience Business Overview
Table 49. Crown Bioscience Preclinical Oncology CRO Product
Table 50. Crown Bioscience Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 51. Crown Bioscience Recent Development
Table 52. Charles River Laboratory Company Detail
Table 53. Charles River Laboratory Business Overview
Table 54. Charles River Laboratory Preclinical Oncology CRO Product
Table 55. Charles River Laboratory Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 56. Charles River Laboratory Recent Development
Table 57. ICON Plc. Company Detail
Table 58. ICON Plc. Business Overview
Table 59. ICON Plc. Preclinical Oncology CRO Product
Table 60. ICON Plc. Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 61. ICON Plc. Recent Development
Table 62. Eurofins Scientific Company Detail
Table 63. Eurofins Scientific Business Overview
Table 64. Eurofins Scientific Preclinical Oncology CRO Product
Table 65. Eurofins Scientific Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 66. Eurofins Scientific Recent Development
Table 67. Taconic Biosciences Company Detail
Table 68. Taconic Biosciences Business Overview
Table 69. Taconic Biosciences Preclinical Oncology CRO Product
Table 70. Taconic Biosciences Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 71. Taconic Biosciences Recent Development
Table 72. Covance Company Detail
Table 73. Covance Business Overview
Table 74. Covance Preclinical Oncology CRO Product
Table 75. Covance Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 76. Covance Recent Development
Table 77. EVOTEC Company Detail
Table 78. EVOTEC Business Overview
Table 79. EVOTEC Preclinical Oncology CRO Product
Table 80. EVOTEC Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 81. EVOTEC Recent Development
Table 82. The Jackson Laboratory Company Detail
Table 83. The Jackson Laboratory Business Overview
Table 84. The Jackson Laboratory Preclinical Oncology CRO Product
Table 85. The Jackson Laboratory Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 86. The Jackson Laboratory Recent Development
Table 87. Wuxi AppTec. Company Detail
Table 88. Wuxi AppTec. Business Overview
Table 89. Wuxi AppTec. Preclinical Oncology CRO Product
Table 90. Wuxi AppTec. Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 91. Wuxi AppTec. Recent Development
Table 92. MI Bioresearch, Inc. Company Detail
Table 93. MI Bioresearch, Inc. Business Overview
Table 94. MI Bioresearch, Inc. Preclinical Oncology CRO Product
Table 95. MI Bioresearch, Inc. Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 96. MI Bioresearch, Inc. Recent Development
Table 97. Champion Oncology, Inc. Company Detail
Table 98. Champion Oncology, Inc. Business Overview
Table 99. Champion Oncology, Inc. Preclinical Oncology CRO Product
Table 100. Champion Oncology, Inc. Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 101. Champion Oncology, Inc. Recent Development
Table 102. Xentech Company Detail
Table 103. Xentech Business Overview
Table 104. Xentech Preclinical Oncology CRO Product
Table 105. Xentech Revenue in Preclinical Oncology CRO Business (2019-2024) & (US$ Million)
Table 106. Xentech Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preclinical Oncology CRO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Preclinical Oncology CRO Market Share by Type: 2023 VS 2030
Figure 3. Blood Cancer Features
Figure 4. Solid Tumors Features
Figure 5. Other Features
Figure 6. Global Preclinical Oncology CRO Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Preclinical Oncology CRO Market Share by Application: 2023 VS 2030
Figure 8. In Vitro Case Studies
Figure 9. In Vivo Case Studies
Figure 10. Preclinical Oncology CRO Report Years Considered
Figure 11. Global Preclinical Oncology CRO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Preclinical Oncology CRO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Preclinical Oncology CRO Market Share by Region: 2023 VS 2030
Figure 14. Global Preclinical Oncology CRO Market Share by Players in 2023
Figure 15. Global Top Preclinical Oncology CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Oncology CRO as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Preclinical Oncology CRO Revenue in 2023
Figure 17. North America Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Preclinical Oncology CRO Market Share by Country (2019-2030)
Figure 19. United States Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Preclinical Oncology CRO Market Share by Country (2019-2030)
Figure 23. Germany Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Preclinical Oncology CRO Market Share by Region (2019-2030)
Figure 31. China Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Preclinical Oncology CRO Market Share by Country (2019-2030)
Figure 39. Mexico Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Preclinical Oncology CRO Market Share by Country (2019-2030)
Figure 43. Turkey Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Preclinical Oncology CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Crown Bioscience Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 46. Charles River Laboratory Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 47. ICON Plc. Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 48. Eurofins Scientific Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 49. Taconic Biosciences Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 50. Covance Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 51. EVOTEC Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 52. The Jackson Laboratory Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 53. Wuxi AppTec. Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 54. MI Bioresearch, Inc. Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 55. Champion Oncology, Inc. Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 56. Xentech Revenue Growth Rate in Preclinical Oncology CRO Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
